Pelvic%20inflammatory%20disease Management
Follow Up
- Further review 4 wk after treatment may be useful to ensure the following:
- Adequate clinical response
- Compliance w/ oral antibiotics
- Screening & treatment of sex partners/contacts
- Recurrence prevention through condom use
- Repeat testing for etiologic organisms may be warranted for patients w/ persistent symptoms, poor compliance w/ antibiotics, or possible reinfection
- In patients w/ documented infection w/ C trachomatis & N gonorrhoeae, some specialists recommend rescreening 4-6 wk after completion of treatment
Counselling
- STI consultation allows for an opportunity to discuss patient’s risk factors for STIs & HIV
- Determine patient’s risk for HIV & discuss HIV testing
- Testing for HIV is recommended & should be offered to all persons seeking evaluation & treatment for STIs
- Pretest & posttest counseling as well as informed consent are part of the testing procedure
- Concomitant infection w/ HIV may complicate management & control of some STIs
- HIV-infected patients w/ PID are more common to have tubo-ovarian abscess & usually require surgical intervention